Invivo Therapeutics Holdings Corp  

(Public, OTCMKTS:NVIV)   Watch this stock  
Find more results for OTC:NVIV
+0.01 (0.93%)
After Hours: 1.09 +0.01 (0.93%)
Dec 17, 4:00PM EST  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 1.06 - 1.09
52 week 0.47 - 2.67
Open 1.09
Vol / Avg. 334,912.00/638,906.00
Mkt cap 101.03M
P/E     -
Div/yield     -
EPS -0.18
Shares 93.55M
Beta 17.21
Inst. own 11%
Nov 5, 2014
Q3 2014 InVivo Therapeutics Holdings Corp Earnings Release

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -22.11% -233.76%
Return on average equity -35.30% -732.67%
Employees 45 -
CDP Score - -


Suite B14402, One Kendall Square
United States - Map
+1-617-8635500 (Phone)

Website links


InVivo Therapeutics Holdings Corp., formerly Design Source, Inc. is a development-stage company. The Company is developing and commercializing technologies for the treatment of spinal cord injuries. The Company develops biopolymer scaffolding devices for the treatment of spinal cord injuries. The biopolymer devices are designed to protect the damaged spinal cord from further secondary injury and promote neuroplasticity, a process where functional recovery can occur through the rerouting of signalling pathways to the spared healthy tissue. The Company�s biopolymer-based devices are surgically implanted or injected into the lesion created during traumatic injury, or the primary injury. The Company�s porous biopolymer scaffold consists of polylactic-co-glycolic acid (PLGA) and-polylysine. The Company focuses to develop an injectable hydrogel designed to counteract the inflammatory environment.

Officers and directors

Mark D. Perrin Chief Executive Officer, Director
Age: 57
Steven F. McAllister Chief Financial Officer
Age: 56
Tamara L. Joseph J.D. Senior Vice President, Chief Compliance Officer, General Counsel
Age: 51
Thomas R. Ulich M.D. Chief Scientific Officer
Age: 60
John A. McCarthy Jr. Non-Executive Independent Chairman of the Board
Age: 54
Daniel R. Marshak Ph.D. Director
Age: 56
Ann Merrifield Director
Kenneth A. Di Pietro Independent Director
Age: 55
Richard J. Roberts Ph.D. Independent Director
Age: 70